Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Patient Monitoring

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2081117

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2081117

Patient Monitoring Devices Market By Product (Multiparameter, Glucose CGM, Wearables, EEG, EMG, ECG, ILR, MCT, Pulse Oximeter, Fetal, Neonatal, BP, Hemodynamic, Spirometer, Capnograph), End User (Hospital, ICU, ASC), & Region - Global Forecast to 2031

PUBLISHED:
PAGES: 453 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The patient monitoring devices market is projected to reach USD 76.11 billion by 2031, up from USD 55.60 billion in 2026, at a CAGR of 6.4%.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsProduct, End user, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries

Continuous technological innovation and increasing adoption of connected healthcare technologies are significantly driving growth in the patient monitoring devices market. Advancements in patient monitoring systems, including wearable devices, continuous glucose monitoring (CGM), remote patient monitoring platforms, and AI-enabled analytics, offer real-time health tracking, improved clinical decision-making, and enhanced patient outcomes. These technologies support continuous monitoring, reduce dependence on hospitals, and enable early detection of health deterioration. Additionally, innovations in device design have led to compact, wireless, and user-friendly systems, making them more suitable for hospital and home-care settings. Manufacturers are increasingly integrating smart features such as cloud connectivity, mobile applications, predictive analytics, and telehealth compatibility. This ongoing innovation cycle is accelerating the replacement of traditional monitoring systems and driving sustained global demand for advanced patient monitoring devices.

Patient Monitoring Devices Market - IMG1

Based on product: The patient monitoring devices market includes multiparameter monitors, blood glucose monitoring devices (CGM and SMBG), wearable monitoring devices, EEG, EMG, ICP, ECG, ILR, MCT, pulse oximeters, fetal & neonatal monitors, blood pressure monitoring devices, hemodynamic monitoring systems, spirometers, and capnography devices. Among these, blood glucose monitoring devices, particularly continuous glucose monitoring (CGM) systems, represent a major growth-driving subsegment. The dominance of this segment is driven primarily by the rising global prevalence of diabetes and the growing need for continuous disease management. CGM and wearable glucose monitoring devices provide real-time glucose insights that support timely treatment decisions and improve patient outcomes. Strong adoption across hospitals, clinics, and home care settings, coupled with rising demand for preventive healthcare, home-based monitoring, smartphone connectivity, and connected healthcare platforms, continues to strengthen the market position of blood glucose monitoring devices.

Based on end user: Hospitals and clinics account for the largest share of the patient monitoring devices market due to their central role in managing acute and chronic conditions requiring continuous patient surveillance. These facilities routinely utilize patient monitoring systems across general wards, intensive care units (ICUs), and emergency & trauma centers to track critical parameters such as heart rate, blood pressure, oxygen saturation, and glucose levels. The growing prevalence of cardiovascular diseases, diabetes, and respiratory disorders has significantly increased demand for real-time monitoring and early clinical intervention. Additionally, hospitals and clinics benefit from advanced healthcare infrastructure, skilled professionals, and integration of connected monitoring technologies. Ongoing investments in critical care capabilities and digital healthcare solutions further drive the adoption of patient monitoring devices, reinforcing the dominance of hospitals and clinics in the market.

North America's well-developed healthcare infrastructure plays a crucial role in supporting the widespread adoption of patient monitoring devices. The region has an extensive network of hospitals, specialty clinics, and advanced care facilities equipped with modern monitoring technologies to efficiently manage acute and chronic conditions. Healthcare systems across the US and Canada are characterized by strong clinical protocols, high healthcare spending, and highly trained professionals, enabling seamless integration of patient monitoring solutions into routine care. Additionally, the growing adoption of continuous glucose monitoring systems, cardiac monitoring devices, wearable technologies, and remote patient monitoring platforms supports early diagnosis and timely intervention. Regular investments in digital health technologies and continuous upgrades of monitoring systems further contribute to sustained demand. The presence of a robust healthcare ecosystem ensures consistent utilization and adoption of patient monitoring devices across multiple care settings.

A breakdown of the primary respondents (supply-side) for the patient monitoring devices market referred to in this report is provided below:

  • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
  • By Designation: C-level: 55%, Director Level: 27%, and Others: 18%
  • By Region: North America: 34%, Europe: 27%, Asia Pacific: 30%, Latin America: 6%, Middle East & Africa: 2% and GCC Countries: 2%

Prominent players in the patient monitoring devices market include Medtronic Plc (Ireland), Abbott Laboratories (US), Dexcom, Inc. (US), GE HealthCare (US), Philips Healthcare (Netherlands), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), Edwards Lifesciences Corporation (US), Getinge AB (Sweden), Baxter International Inc. (US), Dragerwerk AG & Co. KGaA (Germany), Boston Scientific Corporation (US), Masimo Corporation (US), Omron Corporation (Japan), ARCHIMED SAS (Natus Medical) (France), Compumedics Limited (Australia), and Nonin Medical, Inc. (US), among others.

Research Coverage

The report evaluates the patient monitoring devices market and estimates the market size and future growth potential of this market based on various segments, including product, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will assist market leaders and new entrants in the patient monitoring devices market with data on the nearest approximations of revenue figures for the overall market and its subsegments. The report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and develop effective go-to-market strategies. It also enables stakeholders to understand market dynamics and provides insights into key drivers, restraints, challenges, and growth opportunities influencing the patient monitoring devices market.

This report provides insights into the following points:

  • Analysis of key drivers (rising prevalence of chronic diseases such as diabetes and cardiovascular disorders, growing aging population requiring continuous monitoring and long-term healthcare management, increasing demand for remote patient monitoring and home healthcare solutions, rapid adoption of wearable and connected healthcare technologies, technological advancements in AI-enabled and cloud-integrated monitoring systems), restraints (high cost of advanced monitoring systems, data privacy and cybersecurity concerns, stringent regulatory approval requirements for medical devices), opportunities (expansion of remote patient monitoring platforms, development of low-cost and portable monitoring devices, growing adoption of home-based and preventive healthcare solutions), and challenges (limited healthcare infrastructure in developing regions, interoperability issues across connected monitoring platforms, reimbursement and adoption barriers in emerging markets)
  • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global patient monitoring devices market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, end user, and region.
  • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global patient monitoring devices market
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global patient monitoring devices market
Show more
Product Code: MD 2436

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND START DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 PATIENT MONITORING DEVICES MARKET OVERVIEW
  • 3.2 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT AND COUNTRY (2025)
  • 3.3 PATIENT MONITORING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 3.4 PATIENT MONITORING DEVICES MARKET, BY REGION (2024-2031)
  • 3.5 PATIENT MONITORING DEVICES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Emergence of predictive analytics in vital sign monitors
      • 4.2.1.2 Growing preference for wearable patient monitoring devices, biosensors, and smart implants
      • 4.2.1.3 Availability of wireless monitoring devices
      • 4.2.1.4 Expansion of telehealth services and remote monitoring capabilities
      • 4.2.1.5 Growing incidence of chronic diseases
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Risks associated with invasive monitoring devices
      • 4.2.2.2 High cost of patient monitoring products and inadequate reimbursement
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Integration with electronic health records (EHRs)
      • 4.2.3.2 Expansion of remote patient monitoring in home healthcare settings
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Lack of personnel and limited awareness & education for patient monitoring devices
      • 4.2.4.2 Increased pricing pressure on market players
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN PATIENT MONITORING DEVICES MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL PATIENT MONITORING DEVICES INDUSTRY
    • 5.2.4 TRENDS IN GLOBAL HEALTHCARE & MEDICAL DEVICES INDUSTRY
  • 5.3 SUPPLY CHAIN ANALYSIS
    • 5.3.1 PROMINENT COMPANIES
    • 5.3.2 SMALL & MEDIUM-SIZED COMPANIES
    • 5.3.3 END USERS
  • 5.4 VALUE CHAIN ANALYSIS
    • 5.4.1 RESEARCH & DEVELOPMENT
    • 5.4.2 PROCUREMENT AND PRODUCT DEVELOPMENT
    • 5.4.3 MARKETING, SALES, DISTRIBUTION, AND POST-SALES SERVICES
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 AVERAGE SELLING PRICE, BY PRODUCT (2025)
    • 5.6.2 AVERAGE SELLING PRICE, BY REGION (2025)
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT SCENARIO (HS CODE 9018)
    • 5.7.2 EXPORT DATA (HS CODE 9018)
  • 5.8 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.10 INVESTMENT AND FUNDING SCENARIO
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 CASE STUDY 1: SCALING REMOTE CARDIAC MONITORING
    • 5.11.2 CASE STUDY 2: IMPROVING CHRONIC DISEASE MANAGEMENT THROUGH RPM
    • 5.11.3 CASE STUDY 3: ENHANCING PATIENT SURVEILLANCE IN ACUTE CARE SETTINGS
  • 5.12 IMPACT OF US TARIFFS-PATIENT MONITORING DEVICES MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 IMPACT ON COUNTRIES/REGIONS
      • 5.12.4.1 North America
      • 5.12.4.2 Europe
      • 5.12.4.3 Asia Pacific
    • 5.12.5 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 SMART WEARABLE MONITORING DEVICES
    • 6.1.2 VITAL SIGN MONITORS
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 REMOTE PATIENT MONITORS
    • 6.2.2 AI & IOT
  • 6.3 TECHNOLOGY/PRODUCT ROADMAP
    • 6.3.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
    • 6.3.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
    • 6.3.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
  • 6.4 PATENT ANALYSIS
    • 6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 6.5 FUTURE APPLICATIONS
    • 6.5.1 AI-ENABLED REMOTE PATIENT MONITORING & PREDICTIVE HEALTH ANALYTICS
    • 6.5.2 HOME-BASED CHRONIC DISEASE MANAGEMENT & TELEHEALTH INTEGRATION
    • 6.5.3 SMART HOSPITALS & INTEGRATED CLINICAL MONITORING NETWORKS
  • 6.6 IMPACT OF AI/GEN AI ON PATIENT MONITORING DEVICES MARKET
    • 6.6.1 TOP USE CASES AND MARKET POTENTIAL
    • 6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN PATIENT MONITORING DEVICES MARKET
    • 6.6.3 INTERCONNECTED/ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
    • 6.6.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PATIENT MONITORING DEVICES MARKET

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 KEY BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 PATIENT MONITORING DEVICES MARKET, BY PRODUCT

  • 9.1 INTRODUCTION
  • 9.2 BLOOD GLUCOSE MONITORING DEVICES
    • 9.2.1 SELF-MONITORING BLOOD GLUCOSE DEVICES
      • 9.2.1.1 Rising adoption of integrated glucose monitoring devices to drive growth
    • 9.2.2 CONTINUOUS GLUCOSE MONITORING DEVICES
      • 9.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring devices to drive market growth
    • 9.2.3 WEARABLE GLUCOSE MONITORING DEVICES
      • 9.2.3.1 Growing patient inclination towards wearable monitors to boost the market
  • 9.3 CARDIAC MONITORING DEVICES
    • 9.3.1 ECG DEVICES
      • 9.3.1.1 Low cost and wide applications of ECG devices to drive market growth
    • 9.3.2 IMPLANTABLE LOOP RECORDERS
      • 9.3.2.1 High cost and limited applications to limit growth
    • 9.3.3 EVENT MONITORS
      • 9.3.3.1 Emergence of portable and wireless event monitors to drive market growth
    • 9.3.4 MCT MONITORS
      • 9.3.4.1 Availability of alternate technologies to hinder market growth
    • 9.3.5 SMART/WEARABLE ECG MONITORS
      • 9.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors
  • 9.4 MULTIPARAMETER MONITORING DEVICES
    • 9.4.1 LOW-ACUITY MONITORS
      • 9.4.1.1 Increasing adoption of low-acuity monitors in general wards to drive market growth
    • 9.4.2 MID-ACUITY MONITORS
      • 9.4.2.1 Rising geriatric population to increase market growth
    • 9.4.3 HIGH-ACUITY MONITORS
      • 9.4.3.1 Increasing partnerships between manufacturers and hospitals & clinics to drive device sales
  • 9.5 RESPIRATORY MONITORING DEVICES
    • 9.5.1 PULSE OXIMETERS
      • 9.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth
    • 9.5.2 SPIROMETERS
      • 9.5.2.1 Technological advancements to increase adoption of spirometers
    • 9.5.3 CAPNOGRAPHS
      • 9.5.3.1 Product development and growing commercial acceptance to drive market growth
    • 9.5.4 PEAK FLOW METERS
      • 9.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices, to hinder market growth
  • 9.6 TEMPERATURE MONITORING DEVICES
    • 9.6.1 HANDHELD TEMPERATURE MONITORING DEVICES
      • 9.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth
    • 9.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES
      • 9.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices
    • 9.6.3 WEARABLE CONTINUOUS MONITORING DEVICES
      • 9.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand
    • 9.6.4 INVASIVE TEMPERATURE MONITORING DEVICES
      • 9.6.4.1 Risk of bloodstream infections associated with catheter usage to hinder market for invasive devices
    • 9.6.5 SMART TEMPERATURE MONITORING PATCHES
      • 9.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth
  • 9.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES
    • 9.7.1 HEMODYNAMIC MONITORS
      • 9.7.1.1 Influx of VC funding to drive market growth
    • 9.7.2 BLOOD PRESSURE MONITORS
      • 9.7.2.1 Development of wearable blood pressure monitors to drive market growth
    • 9.7.3 DISPOSABLES
      • 9.7.3.1 Growing number of surgical procedures to drive growth in disposables market
  • 9.8 FETAL & NEONATAL MONITORING DEVICES
    • 9.8.1 FETAL MONITORING DEVICES
      • 9.8.1.1 Rising prevalence of obstetric complications to drive market growth
    • 9.8.2 NEONATAL MONITORING DEVICES
      • 9.8.2.1 Rising number of neonatal care facilities worldwide to drive market
  • 9.9 NEUROMONITORING DEVICES
    • 9.9.1 EEG MACHINES
      • 9.9.1.1 Growing applications and technological advancements to favor market growth
    • 9.9.2 EMG MACHINES
      • 9.9.2.1 Availability of reimbursements for EMG-assisted surgeries to boost product demand
    • 9.9.3 CEREBRAL OXIMETERS
      • 9.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth
    • 9.9.4 ICP MONITORS
      • 9.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs to support adoption of ICP monitors
    • 9.9.5 MEG MACHINES
      • 9.9.5.1 High implementation and maintenance costs of MEG devices hinder market growth
    • 9.9.6 TCD MACHINES
      • 9.9.6.1 Rising prevalence of strokes and cerebrovascular disorders to contribute to market growth
  • 9.10 WEIGHT MONITORING DEVICES
    • 9.10.1 DIGITAL WEIGHT MONITORING DEVICES
      • 9.10.1.1 Consumer preference for digital scales-a key market driver
    • 9.10.2 ANALOG WEIGHT MONITORING DEVICES
      • 9.10.2.1 Rising prevalence of obesity and low cost of analog scales to support market growth
  • 9.11 OTHER PATIENT MONITORING DEVICES

10 PATIENT MONITORING DEVICES MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & CLINICS
    • 10.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF PATIENT MONITORING TECHNOLOGIES TO BOOST MARKET
  • 10.3 AMBULATORY SURGICAL CENTERS
    • 10.3.1 COST-EFFECTIVENESS AND CONVENIENCE TO DRIVE DEMAND FOR AMBULATORY CARE
  • 10.4 HOME CARE SETTINGS
    • 10.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH
  • 10.5 OTHER END USERS

11 PATIENT MONITORING DEVICES MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 Growing number of FDA approvals for patient monitoring devices to support market growth
    • 11.2.2 CANADA
      • 11.2.2.1 Growing public-private funding for research to drive market growth
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
    • 11.3.2 UK
      • 11.3.2.1 Increasing public & private investments to contribute to market growth
    • 11.3.3 FRANCE
      • 11.3.3.1 Statutory health insurance system to support market growth
    • 11.3.4 ITALY
      • 11.3.4.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices
    • 11.3.5 SPAIN
      • 11.3.5.1 Growing number of surgical procedures to drive market growth in Spain
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 JAPAN
      • 11.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth
    • 11.4.2 CHINA
      • 11.4.2.1 Growing focus of local and international market players to favor market growth
    • 11.4.3 INDIA
      • 11.4.3.1 Increasing government-implemented healthcare initiatives to support market growth
    • 11.4.4 AUSTRALIA
      • 11.4.4.1 R&D tax incentive program to support market growth
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Supportive government initiatives to drive market growth
    • 11.4.6 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 BRAZIL
      • 11.5.1.1 Brazil to dominate LATAM market
    • 11.5.2 MEXICO
      • 11.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
    • 11.5.3 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES
  • 11.7 GCC COUNTRIES
    • 11.7.1 HEALTHCARE DIGITALIZATION INITIATIVES TO ACCELERATE PATIENT MONITORING DEVICE ADOPTION IN GCC

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
    • 12.4.1 GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
    • 12.4.2 GLOBAL CARDIAC MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
    • 12.4.3 GLOBAL MULTIPARAMETER MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
    • 12.4.4 GLOBAL HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
    • 12.4.5 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Product footprint
      • 12.5.5.4 End-user footprint
  • 12.6 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of key startups/SMEs, 2025
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES & APPROVALS
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 MEDTRONIC
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches & approvals
        • 13.1.1.3.2 Deals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 ABBOTT LABORATORIES
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches & approvals
        • 13.1.2.3.2 Deals
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses & competitive threats
    • 13.1.3 DEXCOM, INC.
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Product launches & approvals
        • 13.1.3.3.2 Deals
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses & competitive threats
    • 13.1.4 GE HEALTHCARE
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches & approvals
        • 13.1.4.3.2 Deals
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses & competitive threats
    • 13.1.5 PHILIPS HEALTHCARE
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Product launches & approvals
        • 13.1.5.3.2 Deals
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Right to win
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses & competitive threats
    • 13.1.6 NIHON KOHDEN CORPORATION
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product launches & approvals
        • 13.1.6.3.2 Deals
    • 13.1.7 MINDRAY MEDICAL INTERNATIONAL LTD.
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Product launches & approvals
        • 13.1.7.3.2 Deals
    • 13.1.8 BD
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
    • 13.1.9 GETINGE AB
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product launches, enhancements, and approvals
        • 13.1.9.3.2 Deals
    • 13.1.10 BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC.)
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
    • 13.1.11 DRAGERWERK AG & CO. KGAA
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
    • 13.1.12 BOSTON SCIENTIFIC CORPORATION
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Deals
    • 13.1.13 MASIMO CORPORATION
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
    • 13.1.14 OMRON CORPORATION
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
    • 13.1.15 ARCHIMED SAS (NATUS MEDICAL)
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Deals
    • 13.1.16 COMPUMEDICS LIMITED
      • 13.1.16.1 Business overview
      • 13.1.16.2 Products offered
      • 13.1.16.3 Recent developments
        • 13.1.16.3.1 Deals
    • 13.1.17 NONIN MEDICAL, INC.
      • 13.1.17.1 Business overview
      • 13.1.17.2 Products offered
      • 13.1.17.3 Recent developments
        • 13.1.17.3.1 Product launches & approvals
  • 13.2 OTHER PLAYERS
    • 13.2.1 BIOTRONIK
    • 13.2.2 SCHILLER AG
    • 13.2.3 SENSEONICS
    • 13.2.4 CARDIOMO
    • 13.2.5 VITLS
    • 13.2.6 NETEERA
    • 13.2.7 QARDIO
    • 13.2.8 VIVIFY HEALTH
    • 13.2.9 IRHYTHM TECHNOLOGIES, INC.
    • 13.2.10 OSYPKA MEDICAL
    • 13.2.11 CARDINAL HEALTH
    • 13.2.12 MERIT MEDICAL SYSTEMS

14 RESEARCH METHODOLOGY

  • 14.1 RESEARCH DATA
    • 14.1.1 SECONDARY DATA
      • 14.1.1.1 Key data from secondary sources
    • 14.1.2 PRIMARY DATA
      • 14.1.2.1 Key data from primary sources
      • 14.1.2.2 Key industry insights
  • 14.2 MARKET SIZE ESTIMATION
  • 14.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 14.4 MARKET SHARE ESTIMATION
  • 14.5 STUDY ASSUMPTIONS
  • 14.6 METHODOLOGY-RELATED LIMITATIONS
  • 14.7 RESEARCH LIMITATIONS
  • 14.8 RISK ASSESSMENT

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
Show more
Product Code: MD 2436

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES TO USD
  • TABLE 2 PATIENT MONITORING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021-2030
  • TABLE 4 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY KEY PLAYER, 2025 (USD)
  • TABLE 5 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY REGION, 2025 (USD)
  • TABLE 6 IMPORT DATA FOR PATIENT MONITORING DEVICES PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 7 EXPORT DATA FOR PATIENT MONITORING DEVICES UNDER HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 8 PATIENT MONITORING DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2026-2027)
  • TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 10 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR PATIENT MONITORING DEVICES
  • TABLE 11 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 12 PATIENT MONITORING DEVICES MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION
  • TABLE 13 INTERCONNECTED/ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 GLOBAL STANDARDS IN PATIENT MONITORING DEVICES MARKET
  • TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES
  • TABLE 21 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES
  • TABLE 22 PATIENT MONITORING DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 23 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 24 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 25 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 26 PATIENT MONITORING DEVICES MARKET VOLUME FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
  • TABLE 27 SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 28 CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 29 WEARABLE GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 30 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 31 CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 32 PATIENT MONITORING DEVICES MARKET VOLUME FOR CARDIAC MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
  • TABLE 33 ECG DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 34 IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 EVENT MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 MCT MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 37 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS
  • TABLE 38 SMART/WEARABLE ECG MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 40 MULTIPARAMETER MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 PATIENT MONITORING DEVICES MARKET VOLUME FOR MULTI-PARAMETER MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
  • TABLE 42 LOW-ACUITY MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 MID-ACUITY MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 HIGH-ACUITY MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 46 RESPIRATORY MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 47 PATIENT MONITORING DEVICES MARKET VOLUME FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
  • TABLE 48 PULSE OXIMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 SPIROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 CAPNOGRAPHS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 PEAK FLOW METERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 52 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 53 TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 PATIENT MONITORING DEVICES MARKET VOLUME FOR TEMPERATURE MONITORING SYSTEMS, BY REGION, 2024-2031 (UNITS)
  • TABLE 55 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS
  • TABLE 56 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS
  • TABLE 59 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS
  • TABLE 62 SMART TEMPERATURE MONITORING PATCHES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 63 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 64 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 PATIENT MONITORING DEVICES MARKET VOLUME FOR HEMODYNAMIC/ PRESSURE MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
  • TABLE 66 HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 67 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS
  • TABLE 68 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 69 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 70 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 71 FETAL & NEONATAL MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 72 PATIENT MONITORING DEVICES MARKET VOLUME FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
  • TABLE 73 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS
  • TABLE 74 FETAL MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 75 NEONATAL MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 76 NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 77 NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 PATIENT MONITORING DEVICES MARKET VOLUME FOR NEUROMONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
  • TABLE 79 EEG MACHINES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 80 EMG MACHINES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 81 CEREBRAL OXIMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 82 ICP MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 83 MEG MACHINES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 84 TCD MACHINES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 85 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 86 WEIGHT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 87 PATIENT MONITORING DEVICES MARKET VOLUME FOR WEIGHT MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
  • TABLE 88 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 89 ANALOG WEIGHT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 90 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS
  • TABLE 91 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS
  • TABLE 92 OTHER PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 93 PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 94 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 95 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 96 PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 97 PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 98 PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 99 PATIENT MONITORING DEVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 100 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 101 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 102 NORTH AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 103 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 104 NORTH AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 105 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 106 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 107 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 108 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 109 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 110 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 111 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 112 US: VC FUNDING IN PATIENT MONITORING DEVICES MARKET
  • TABLE 113 US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 114 US: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 115 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 116 US: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 117 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 118 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 119 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 120 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 121 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 122 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 123 US: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 124 RESEARCH GRANTS IN PATIENT MONITORING DEVICES MARKET IN CANADA
  • TABLE 125 RECENT DEVELOPMENTS IN CANADIAN PATIENT MONITORING DEVICES MARKET
  • TABLE 126 CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 127 CANADA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 128 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 129 CANADA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 130 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 131 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 132 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 133 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 134 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 135 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 136 CANADA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 137 PRODUCT APPROVALS IN EUROPEAN PATIENT MONITORING DEVICES MARKET
  • TABLE 138 EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 139 EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 140 EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 141 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 142 EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 143 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 144 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 145 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 146 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 147 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 148 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 149 EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 150 GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 151 GERMANY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 152 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 153 GERMANY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 154 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 155 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 156 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 157 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 158 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 159 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 160 GERMANY: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 161 UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 162 UK: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 163 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 164 UK: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 165 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 166 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 167 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 168 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 169 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 170 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 171 UK: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 172 FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 173 FRANCE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 174 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 175 FRANCE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 176 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 177 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 178 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 179 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 180 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 181 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 FRANCE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 183 ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 184 ITALY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 185 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 186 ITALY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 187 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 188 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 189 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 190 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 191 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 192 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 193 ITALY: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 194 SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 195 SPAIN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 196 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 197 SPAIN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 198 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 199 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 200 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 201 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 202 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 203 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 204 SPAIN: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 205 REST OF EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 206 REST OF EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 207 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 208 REST OF EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 209 REST OF EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 210 REST OF EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 211 REST OF EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 212 REST OF EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 213 REST OF EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 214 REST OF EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 215 REST OF EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 225 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 227 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 228 JAPAN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 229 JAPAN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 231 JAPAN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 232 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 233 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 234 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 235 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 236 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 237 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 238 JAPAN: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 239 CHINA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 240 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 241 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 242 CHINA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 243 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 244 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 245 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 246 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 247 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 248 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 249 CHINA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 250 INDIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 251 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 252 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 253 INDIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 254 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 255 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 256 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 257 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 258 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 259 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 260 INDIA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 261 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 262 AUSTRALIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 263 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 264 AUSTRALIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 265 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 266 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 267 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 268 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 269 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 270 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 271 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 272 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 273 SOUTH KOREA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 274 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 275 SOUTH KOREA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 276 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 277 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 278 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 279 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 280 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 281 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 282 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 283 REST OF ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 284 REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 286 REST OF ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 287 REST OF ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 288 REST OF ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 289 REST OF ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 290 REST OF ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 291 REST OF ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 292 REST OF ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 293 REST OF ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 294 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 295 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 296 LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 297 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 298 LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 299 LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 300 LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 301 LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 302 LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 303 LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 304 LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 305 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 306 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 307 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 308 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 309 BRAZIL: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 310 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 311 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 312 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 313 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 314 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 315 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 316 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 317 MEXICO: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 318 MEXICO: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 319 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 320 MEXICO: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 321 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 322 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 323 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 324 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 325 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 326 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 327 MEXICO: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 328 REST OF LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 329 REST OF LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 330 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 331 REST OF LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 332 REST OF LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 333 REST OF LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 334 REST OF LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 335 REST OF LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 336 REST OF LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 337 REST OF LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 338 REST OF LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 339 MIDDLE EAST & AFRICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 340 MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 341 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 342 MIDDLE EAST & AFRICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 343 MIDDLE EAST & AFRICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 344 MIDDLE EAST & AFRICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 345 MIDDLE EAST & AFRICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 346 MIDDLE EAST & AFRICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 347 MIDDLE EAST & AFRICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 348 MIDDLE EAST & AFRICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 349 MIDDLE EAST & AFRICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 350 GCC COUNTRIES: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 351 GCC COUNTRIES: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 352 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 353 GCC COUNTRIES: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 354 GCC COUNTRIES: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 355 GCC COUNTRIES: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 356 GCC COUNTRIES: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 357 GCC COUNTRIES: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 358 GCC COUNTRIES: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 359 GCC COUNTRIES: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 360 GCC COUNTRIES: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 361 KEY DEVELOPMENTS IN PATIENT MONITORING DEVICES MARKET, JANUARY 2022-JUNE 2026
  • TABLE 362 PATIENT MONITORING MARKET: DEGREE OF COMPETITION
  • TABLE 363 PATIENT MONITORING DEVICES MARKET: REGION FOOTPRINT (17 COMPANIES)
  • TABLE 364 PATIENT MONITORING DEVICES MARKET: PRODUCT FOOTPRINT (17 COMPANIES)
  • TABLE 365 PATIENT MONITORING DEVICES MARKET: END-USER FOOTPRINT (17 COMPANIES)
  • TABLE 366 PATIENT MONITORING DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 367 PATIENT MONITORING DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, 2025
  • TABLE 368 PATIENT MONITORING DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-JANUARY 2026
  • TABLE 369 PATIENT MONITORING DEVICES MARKET: DEALS, JANUARY 2022-JANUARY 2026
  • TABLE 370 PATIENT MONITORING DEVICES MARKET: EXPANSIONS, JANUARY 2022-JANUARY 2026
  • TABLE 371 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 372 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 373 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS
  • TABLE 374 MEDTRONIC PLC: DEALS
  • TABLE 375 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 376 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 377 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS
  • TABLE 378 ABBOTT LABORATORIES: DEALS
  • TABLE 379 DEXCOM, INC.: COMPANY OVERVIEW
  • TABLE 380 DEXCOM, INC.: PRODUCTS OFFERED
  • TABLE 381 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS
  • TABLE 382 DEXCOM, INC.: DEALS
  • TABLE 383 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 384 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 385 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
  • TABLE 386 GE HEALTHCARE: DEALS
  • TABLE 387 PHILIPS HEALTHCARE: COMPANY OVERVIEW
  • TABLE 388 PHILIPS HEALTHCARE: PRODUCTS OFFERED
  • TABLE 389 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
  • TABLE 390 PHILIPS HEALTHCARE: DEALS
  • TABLE 391 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 392 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
  • TABLE 393 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 394 NIHON KOHDEN CORPORATION: DEALS
  • TABLE 395 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY OVERVIEW
  • TABLE 396 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCTS OFFERED
  • TABLE 397 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCT LAUNCHES & APPROVALS
  • TABLE 398 MINDRAY MEDICAL INTERNATIONAL LTD.: DEALS
  • TABLE 399 BD: COMPANY OVERVIEW
  • TABLE 400 BD: PRODUCTS OFFERED
  • TABLE 401 GETINGE AB: COMPANY OVERVIEW
  • TABLE 402 GETINGE AB: PRODUCTS OFFERED
  • TABLE 403 GETTING AB: PRODUCT ENHANCEMENTS, AND APPROVALS
  • TABLE 404 GETTING AB: DEALS
  • TABLE 405 BAXTER INTERNATIONAL: COMPANY OVERVIEW
  • TABLE 406 BAXTER INTERNATIONAL: PRODUCTS OFFERED
  • TABLE 407 DRAGERWERK AG & CO. KGAA: COMPANY OVERVIEW
  • TABLE 408 DRAGERWERK AG & CO. KGAA: PRODUCTS OFFERED
  • TABLE 409 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 410 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 411 BOSTON SCIENTIFIC CORPORATION: DEALS
  • TABLE 412 MASIMO CORPORATION: COMPANY OVERVIEW
  • TABLE 413 MASIMO CORPORATION: PRODUCTS OFFERED
  • TABLE 414 OMRON CORPORATION: COMPANY OVERVIEW
  • TABLE 415 OMRON CORPORATION: PRODUCTS OFFERED
  • TABLE 416 ARCHIMED SAS: BUSINESS OVERVIEW
  • TABLE 417 ARCHIMED SAS (NATUS MEDICAL): PRODUCTS OFFERED
  • TABLE 418 ARCHIMED SAS (NATUS MEDICAL): DEALS
  • TABLE 419 COMPUMEDICS LIMITED: BUSINESS OVERVIEW
  • TABLE 420 COMPUMEDICS LIMITED: PRODUCTS OFFERED
  • TABLE 421 COMPUMEDICS LIMITED: DEALS
  • TABLE 422 NONIN MEDICAL, INC.: BUSINESS OVERVIEW
  • TABLE 423 NONIN MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 424 NONIN MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS
  • TABLE 425 RISK ASSESSMENT: PATIENT MONITORING DEVICES

List of Figures

  • FIGURE 1 PATIENT MONITORING DEVICES MARKET SEGMENTATION
  • FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • FIGURE 3 PATIENT MONITORING DEVICES MARKET, 2026-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT MONITORING DEVICES MARKET
  • FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PATIENT MONITORING DEVICES MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN PATIENT MONITORING DEVICES MARKET, 2026
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 8 STRINGENT REGULATORY FRAMEWORK IN BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH
  • FIGURE 9 HOSPITAL & CLINICS FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2025
  • FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2026 TO 2031
  • FIGURE 11 NORTH AMERICA TO HOLD LARGEST MARKET SHARE TILL 2031
  • FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE
  • FIGURE 13 PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 PATIENT MONITORING DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 15 PATIENT MONITORING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 16 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 17 PATIENT MONITORING DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 18 PATIENT MONITORING DEVICES MARKET: TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS' BUSINESSES
  • FIGURE 19 PATIENT MONITORING DEVICES MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 20 NUMBER OF PATENTS PUBLISHED (JANUARY 2016-JUNE 2026)
  • FIGURE 21 TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT MONITORING DEVICES (JANUARY 2016- JUNE 2026)
  • FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES
  • FIGURE 23 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES
  • FIGURE 24 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT
  • FIGURE 25 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SNAPSHOT
  • FIGURE 26 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT MONITORING DEVICES MARKET, 2021-2025 (USD MILLION)
  • FIGURE 27 BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE ANALYSIS, 2025
  • FIGURE 28 CARDIAC MONITORING DEVICES MARKET SHARE ANALYSIS, 2025
  • FIGURE 29 MULTIPARAMETER MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
  • FIGURE 30 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE ANALYSIS, 2025
  • FIGURE 31 FETAL & NEONATAL MONITORING DEVICES MARKET SHARE ANALYSIS, 2025
  • FIGURE 32 PATIENT MONITORING DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 33 PATIENT MONITORING DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 34 PATIENT MONITORING DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 35 EV/EBITDA OF KEY VENDORS
  • FIGURE 36 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 37 PATIENT MONITORING DEVICES MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 38 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 39 ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 40 DEXCOM, INC.: COMPANY SNAPSHOT
  • FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 42 PHILIPS HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 43 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • FIGURE 44 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY SNAPSHOT
  • FIGURE 45 BD: COMPANY SNAPSHOT
  • FIGURE 46 GETINGE AB.: COMPANY SNAPSHOT
  • FIGURE 47 BAXTER INTERNATIONAL: COMPANY SNAPSHOT
  • FIGURE 48 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT
  • FIGURE 49 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 50 MASIMO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 51 OMRON CORPORATION: COMPANY SNAPSHOT
  • FIGURE 52 COMPUMEDICS LIMITED: COMPANY SNAPSHOT
  • FIGURE 53 RESEARCH DESIGN
  • FIGURE 54 PRIMARY SOURCES
  • FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY/DEMAND-SIDE PARTICIPANTS
  • FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 57 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 58 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC
  • FIGURE 59 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES (2025)
  • FIGURE 60 PATIENT MONITORING DEVICES MARKET: CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2031)
  • FIGURE 61 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 62 DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!